Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cal Gary who wrote (13998)	8/29/2005 4:11:09 PM
From: Cal Gary	Read Replies (1) of 14101

2005 Annual Report online stockwatch.com Really good format that' high lights thier plans and disclaimers. They also present their pipeline potential in a word chart. Transcellular Drug for: osteo onychomycosiis psoriasis acne topical anesthetic and the potential market size for each. In the Q and A section: You have recently hired or retained specialists in intellectual property and licensing. When will you enter into new licensing agreements for key markets such as the U.S.? A > Future R&D will focus on our two technology platforms. In attracting development partners, we must be able to patent any new product under consideration and make sure we are not infringing upon existing patents. We will be looking at potential partners earlier in the development process than we have in the past, with an eye toward capitalizing on the intellectual and financial strengths of the leading industry players. Based on preliminary discussions with potential U.S. Licensees, we are optimistic that during fiscal 2006, we will be able to secure a licensing arrangement with a U.S. partner for Pennsaid and Pennsaid Plus. Sounds confident to make this statement. At least no words like 'imminient' or 'any day now'.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next